litlas
Log inCreate account

Matthias Simon

Active 1991–2025

106
Papers
18,690
Citations
67
h-index
92
i10-index

Citations

Citations per year for Matthias Simon1980: 2 citations1987: 2 citations1995: 1 citations1996: 2 citations1997: 10 citations1998: 8 citations1999: 19 citations2000: 14 citations2001: 10 citations2002: 19 citations2003: 19 citations2004: 23 citations2005: 25 citations2006: 14 citations2007: 32 citations2008: 25 citations2009: 68 citations2010: 107 citations2011: 145 citations2012: 144 citations2013: 168 citations2014: 195 citations2015: 220 citations2016: 199 citations2017: 277 citations2018: 233 citations2019: 662 citations2020: 927 citations2021: 878 citations2022: 519 citations2023: 344 citations2024: 582 citations2025: 192 citations2026: 6 citations1981–1986: no citations, so these years are not shown1988–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,030 citing papers, 24.2% of this breakdownGermany: 965 citing papers, 11.5% of this breakdownChina: 639 citing papers, 7.6% of this breakdownUnited Kingdom: 527 citing papers, 6.3% of this breakdownItaly: 374 citing papers, 4.5% of this breakdownFrance: 351 citing papers, 4.2% of this breakdownNetherlands: 312 citing papers, 3.7% of this breakdownSwitzerland: 308 citing papers, 3.7% of this breakdownCanada: 262 citing papers, 3.1% of this breakdownJapan: 194 citing papers, 2.3% of this breakdownSpain: 184 citing papers, 2.2% of this breakdownAustralia: 175 citing papers, 2.1% of this breakdown
0%24.2%Other 24.6%

Institutions

Fields

  • Medicine64.5%
  • Biochemistry, Genetics and Molecular Biology21.8%
  • Neuroscience2.7%
  • Mathematics2.4%
  • Computer Science2.2%
  • Engineering1.5%
  • Other4.9%

Topics

  • Glioma Diagnosis and Treatment15.6%
  • Meningioma and schwannoma management4.9%
  • Brain Metastases and Treatment4.3%
  • Radiomics and Machine Learning in Medical Imaging2.6%
  • Epigenetics and DNA Methylation2.5%
  • Neurofibromatosis and Schwannoma Cases2%
  • Other68.1%

Coauthors

All papers

Open in search
  1. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

    Authors: Felix Sahm, Daniel Schrimpf, Damian Stichel, David Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David Reuß, David Capper, Dominik Sturm, Hans‐Georg Wirsching, Anna S. Berghoff, Peter Baumgarten, Annekathrin Kratz, Kristin Huang, Annika K. Wefers, Volker Hovestadt, Martin Sill, Hayley Ellis, Kathreena M. Kurian, Ali Fuat Okuducu, Christine Jungk, Katharina Drueschler, Matthias Schick, Melanie Bewerunge‐Hudler, Christian Mawrin, Marcel Seiz‐Rosenhagen, Ralf Ketter, Matthias Simon, Manfred Westphal, Katrin Lamszus, Albert J. Becker, Arend Koch, Jens Schittenhelm, Elisabeth J. Rushing, V. Peter Collins, Stefanie Brehmer, Lukas Chávez, Michael Platten, Daniel Hänggi, Andreas Unterberg, Werner Paulus, Wolfgang Wick, Stefan M. Pfister, Michel Mittelbronn, Matthias Preusser, Christel Herold‐Mende, Michael Weller, Andreas von Deimling - The Lancet Oncology 2017 cited by 854

  2. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

    Authors: Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim P. Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf‐Dieter Kortmann, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Oliver Schnell, Oliver Bähr, Martin Uhl, Clemens Seidel, Ghazaleh Tabatabai, Thomas E. Kowalski, Florian Ringel, Friederike Schmidt‐Graf, Bogdana Suchorska, Stefanie Brehmer, Astrid Weyerbrock, Miriam Renovanz, Lars Bullinger, Norbert Galldiks, Peter Vajkoczy, Martin Misch, Hartmut Vatter, Moritz Stuplich, Niklas Schäfer, Sied Kebir, Johannes Weller, Christina Schaub, Walter Stummer, Jörg‐Christian Tonn, Matthias Simon, Vera C. Keil, Michael Nelles, Horst Urbach, Martin Coenen, Wolfgang Wick, Michael Weller, Rolf Fimmers, Matthias Schmid, Elke Hattingen, Torsten Pietsch, Christoph Coch, Martin Glas - The Lancet 2019 cited by 576

  3. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

    Authors: Wolfgang Wick, Michael Platten, Christoph Meisner, Jörg Felsberg, Ghazaleh Tabatabai, Matthias Simon, Guido Nikkhah, Kirsten Papsdorf, Joachim P. Steinbach, Michael Sabel, Stephanie E. Combs, Jan Vesper, Christian Braun, Jürgen Meixensberger, Ralf Ketter, Regine Mayer‐Steinacker, Guido Reifenberger, Michael Weller - The Lancet Oncology 2012 cited by 1,125

  4. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas

    Authors: Mark W. Youngblood, Daniel Durán, Julio D. Montejo, Chang Li, Sacit Bulent Omay, Koray Özduman, Amar H. Sheth, Amy Zhao, Evgeniya Tyrtova, Danielle Miyagishima, Elena I. Fomchenko, Christopher S. Hong, Victoria Clark, Maximilien Riche, Matthieu Peyre, Julien Boetto, Sadaf Sohrabi, Sarah Koljaka, Jacob F. Baranoski, James Knight, Hongda Zhu, M. Necmettin Pamir, Timuçin Avşar, Türker Kılıç, Johannes Schramm, Marco Timmer, Roland Goldbrunner, Ye Gong, Yaşar Bayri, Nduka Amankulor, Ronald L. Hamilton, Kaya Bilgüvar, Irina Tikhonova, Patrick Tomak, Anita Hüttner, Matthias Simon, Boris Krischek, Michel Kalamarides, E. Zeynep Erson‐Omay, Jennifer Moliterno, Murat Günel - Journal of neurosurgery 2019 cited by 182

  5. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas

    Authors: Victoria Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W. Youngblood, Tong Ihn Lee, Jacob F. Baranoski, A. Gulhan Ercan‐Sencicek, Brian J. Abraham, Abraham S. Weintraub, Denes Hnisz, Matthias Simon, Boris Krischek, E. Zeynep Erson‐Omay, Octavian Henegariu, Geneive Carrión-Grant, Ketu Mishra-Gorur, Daniel Durán, Johanna Goldmann, Johannes Schramm, Roland Goldbrunner, Joseph M. Piepmeier, Alexander O. Vortmeyer, Jennifer Moliterno Günel, Kaya Bilgüvar, Katsuhito Yasuno, Richard A. Young, Murat Günel - Nature Genetics 2016 cited by 357

  6. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

    Authors: Christian Hartmann, Bettina Hentschel, Wolfgang Wick, David Capper, Jörg Felsberg, Matthias Simon, Manfred Westphal, Gabriele Schackert, Richard Meyermann, Torsten Pietsch, Guido Reifenberger, Michael Weller, Markus Loeffler, Andreas von Deimling - Acta Neuropathologica 2010 cited by 843

  7. TERT Promoter Mutations and Risk of Recurrence in Meningioma

    Authors: Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuß, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher, Qianghu Wang, Erik P. Sulman, Sebastian Adeberg, Arend Koch, Ali Fuat Okuducu, Stefanie Brehmer, Jens Schittenhelm, Albert J. Becker, Benjamin Brokinkel, Melissa Schmidt, Theresa Ull, Konstantinos Gousias, Almuth Friederike, Kessler, Katrin Lamszus, Jürgen Debus, Christian Mawrin, Yoo-Jin Kim, Matthias Simon, Ralf Ketter, Werner Paulus, Kenneth Aldape, Christel Herold‐Mende, Andreas von Deimling - JNCI Journal of the National Cancer Institute 2015 cited by 400

  8. Integrated genomic characterization of IDH1-mutant glioma malignant progression

    Authors: Hanwen Bai, Akdes Serin Harmancı, E. Zeynep Erson‐Omay, Jie Li, Süleyman Coşkun, Matthias Simon, Boris Krischek, Koray Özduman, Sacit Bulent Omay, Eric A. Sorensen, Şevin Turcan, Mehmet Bakırcığlu, Geneive Carrión-Grant, Phillip B. Murray, Victoria Clark, A. Gulhan Ercan‐Sencicek, James Knight, Leman Sencar, Selin Altınok, Leon D. Kaulen, Burcu Gülez, Marco Timmer, Johannes Schramm, Ketu Mishra-Gorur, Octavian Henegariu, Jennifer Moliterno, Angeliki Louvi, Timothy A. Chan, Stacey Tannheimer, M. Necmettin Pamir, Alexander O. Vortmeyer, Kaya Bilgüvar, Katsuhito Yasuno, Murat Günel - Nature Genetics 2015 cited by 350

  9. Long-term survival with glioblastoma multiforme

    Authors: Dietmar Krex, Barbara Klink, Christian Hartmann, Andreas von Deimling, Torsten Pietsch, Matthias Simon, Michael Sabel, Joachim P. Steinbach, Oliver Heese, Guido Reifenberger, Michael Weller, Gabriele Schackert, for the German Glioma Network - Brain 2007 cited by 902

  10. 'Go or Grow': the key to the emergence of invasion in tumour progression?

    Authors: Haralampos Hatzikirou, David Basanta, Matthias Simon, Karl Schaller, Andreas Deutsch - Mathematical Medicine and Biology A Journal of the IMA 2010 cited by 378

  11. Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection

    Authors: Florian Ringel, Haiko Pape, Michael Sabel, Dietmar Krex, Hans Bock, Martin Misch, Astrid Weyerbrock, Thomas Westermaier, Christian Senft, Philippe Schucht, Bernhard Meyer, Matthias Simon - Neuro-Oncology 2015 cited by 263

  12. Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression

    Authors: Miriam Ratliff, Kianush Karimian‐Jazi, Dirk C. Hoffmann, Laurèl Rauschenbach, Matthias Simon, Ling Hai, Henriette Mandelbaum, Marc C. Schubert, Tobias Keßler, Stefanie Uhlig, Daniel Domínguez Azorín, Erik Jung, Matthias Osswald, Gergely Solecki, Máté E. Maros, Varun Venkataramani, Martin Glas, Nima Etminan, Björn Scheffler, Wolfgang Wick, Frank Winkler - Neuro-Oncology 2023 cited by 51

  13. A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma

    Authors: Manfred Westphal, Oliver Heese, Joachim P. Steinbach, Oliver Schnell, Gabriele Schackert, H. Maximilian Mehdorn, D. Schulz, Matthias Simon, Uwe Schlegel, Christian Senft, Karsten Geletneky, Christian Braun, Joachim Härtung, Dirk Reuter, Monika Warmuth Metz, F. Bach, Torsten Pietsch - European Journal of Cancer 2015 cited by 203

  14. Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

    Authors: Michael Weller, Jörg Felsberg, Christian Hartmann, Hilmar Berger, Joachim P. Steinbach, Johannes Schramm, Manfred Westphal, Gabriele Schackert, Matthias Simon, Jörg C. Tonn, Oliver Heese, Dietmar Krex, Guido Nikkhah, Torsten Pietsch, Otmar D. Wiestler, Guido Reifenberger, Andreas von Deimling, Markus Loeffler - Journal of Clinical Oncology 2009 cited by 611

  15. Integrated genomic analyses of de novo pathways underlying atypical meningiomas

    Authors: Akdes Serin Harmancı, Mark W. Youngblood, Victoria Clark, Süleyman Coşkun, Octavian Henegariu, Daniel Durán, E. Zeynep Erson‐Omay, Leon D. Kaulen, Tong Ihn Lee, Brian J. Abraham, Matthias Simon, Boris Krischek, Marco Timmer, Roland Goldbrunner, Sacit Bulent Omay, Jacob F. Baranoski, Burçin Baran, Geneive Carrión-Grant, Hanwen Bai, Ketu Mishra-Gorur, Johannes Schramm, Jennifer Moliterno, Alexander O. Vortmeyer, Kaya Bilgüvar, Katsuhito Yasuno, Richard A. Young, Murat Günel - Nature Communications 2017 cited by 217

  16. Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma

    Authors: Konstantinos Gousias, Theocharis Theocharous, Matthias Simon - Biomedicines 2022 cited by 72

  17. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management

    Authors: Konstantinos Gousias, Johannes Schramm, Matthias Simon - Journal of neurosurgery 2016 cited by 221

  18. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy

    Authors: Friedrich-Wilhelm Kreth, Niklas Thon, Matthias Simon, Manfred Westphal, Gabriele Schackert, Guido Nikkhah, Bettina Hentschel, Guido Reifenberger, Torsten Pietsch, Michael Weller, J. C. Tonn - Annals of Oncology 2013 cited by 207

  19. Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR -Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors

    Authors: Jörg Felsberg, Bettina Hentschel, Kerstin Kaulich, Dorothee Gramatzki, Angela Zacher, Bastian Malzkorn, Marcel A. Kamp, Michael Sabel, Matthias Simon, Manfred Westphal, Gabriele Schackert, Jörg C. Tonn, Torsten Pietsch, Andreas von Deimling, Markus Loeffler, Guido Reifenberger, Michael Weller - Clinical Cancer Research 2017 cited by 178

  20. Directed and acyclic synaptic connectivity in the human layer 2-3 cortical microcircuit

    Authors: Yangfan Peng, Antje Bjelde, Pau Vilimelis Aceituno, Franz Xaver Mittermaier, Henrike Planert, Sabine Grosser, Julia Onken, Katharina Faust, Thilo Kalbhenn, Matthias Simon, Helena Radbruch, Pawel Fidzinski, Dietmar Schmitz, Henrik Alle, Martin Holtkamp, Imre Vida, Benjamin F. Grewe, Jörg R. P. Geiger - Science 2024 cited by 46

  21. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

    Authors: Beatrice Melin, Jill S. Barnholtz‐Sloan, Margaret Wrensch, Christoffer Johansen, Dora Il’yasova, Ben Kinnersley, Quinn T. Ostrom, Karim Labrèche, Yanwen Chen, Georgina Armstrong, Yanhong Liu, Jeanette E. Eckel‐Passow, Paul A. Decker, Marianne Labussière, Ahmed Idbaïh, Khê Hoang‐Xuan, Anna Luisa Di Stefano, Karima Mokhtari, Jean‐Yves Delattre, Peter Broderick, Pilar Galán, Konstantinos Gousias, Johannes Schramm, Minouk J. Schoemaker, Sarah Fleming, Stefan Herms, Stefanie Heilmann‐Heimbach, Markus M. Nöthen, Heinz‐Erich Wichmann, Stefan Schreiber, Anthony J. Swerdlow, Mark Lathrop, Matthias Simon, Marc Sanson, Ulrika Andersson, Preetha Rajaraman, Stephen J. Chanock, Martha S. Linet, Zhaoming Wang, Meredith Yeager, John K. Wiencke, Helen M. Hansen, Lucie McCoy, Terri Rice, Matthew Kosel, Hugues Sicotte, Christopher I. Amos, Jonine L. Bernstein, Faith E. Davis, Dan Lachance, Ching C. Lau, Ryan Merrell, Joellen Shildkraut, Francis Ali‐Osman, Siegal Sadetzki, Michael E. Scheurer, Sanjay Shete, Rose Lai, Elizabeth B. Claus, Sara H. Olson, Robert B. Jenkins, Richard S. Houlston, Melissa L. Bondy - Nature Genetics 2017 cited by 378

  22. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

    Authors: Michael Weller, Ruthild G. Weber, Edith Willscher, Vera Riehmer, Bettina Hentschel, Markus Kreuz, Jörg Felsberg, Ulrike Beyer, Henry Loeffler‐Wirth, Kerstin Kaulich, Joachim P. Steinbach, Christian Hartmann, Dorothee Gramatzki, Johannes Schramm, Manfred Westphal, Gabriele Schackert, Matthias Simon, Tobias Martens, Jan Boström, Christian Hagel, Michael Sabel, Dietmar Krex, Jörg C. Tonn, Wolfgang Wick, Susan Noell, Uwe Schlegel, Bernhard Radlwimmer, Torsten Pietsch, Markus Loeffler, Andreas von Deimling, Hans Binder, Guido Reifenberger - Acta Neuropathologica 2015 cited by 316

  23. TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

    Authors: Matthias Simon, Md. Ismail Hosen, Konstantinos Gousias, P. Sivaramakrishna Rachakonda, Barbara Heidenreich, Marco Gessi, Johannes Schramm, Kari Hemminki, Andreas Waha, Rajiv Kumar - Neuro-Oncology 2014 cited by 240

  24. A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells

    Authors: Christian Kaltschmidt, Constanze Banz‐Jansen, Tahar Benhidjeb, Morris Beshay, Christine Förster, Johannes F. W. Greiner, Eckard Hamelmann, Norbert Jorch, Fritz Mertzlufft, Jesco Pfitzenmaier, Matthias Simon, Jan Schulte Am Esch, Thomas Vordemvenne, Dirk Wähnert, Florian Weißinger, Ludwig Wilkens, Barbara Kaltschmidt - Cancers 2019 cited by 103